Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5142-5150
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5142
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5142
Figure 3 Effect of t10c12 on the protein expression of ErbB1, ErbB2, ErbB3, HRG, and the p85 subunit of PI3K.
HT-29 cells were treated with various concentrations of t10c12 for 3 d. Cell lysates were subjected to immunoblotting with an antibody against ErbB1, ErbB2, ErbB3, p85 subunit of PI3K, HRG, or β-actin. A: Photographs of chemiluminescent detection of the blots, which were representative of three independent experiments, are shown; B: Quantitative analysis of immunoblots. The relative abundance of each band was estimated by densitometric scanning of the exposed films. Each bar represents the mean±SE (n = 3). Comparisons between groups that yielded significant differences are indicated by different letters above each bar. For example, aP<0.05 vs 0 μmol/L t10c12, cP<0.05 vs 1 μmol/L t10c12, eP<0.05 vs 2 μmol/L t10c12.
- Citation: Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, Kwon DY, Park JHY. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 2005; 11(33): 5142-5150
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5142.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5142